TickerGuard
Buy Day today: Poor (44) Weak market breadth · today: Core PCE (August) ≈
DGX

Quest Diagnostics Incorporated

Healthcare · Diagnostics & Research

233.00$ -0.7% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Cash Flow

Quest Diagnostics Incorporated (DGX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at 468 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow DGX
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
301 304 196 294 362 323 180 323 402 295 275 321 299 348 247 355 862 541 731 460 561 481 480 402 502 334 94 444 207 527 154 360 356 464 314 544 563 465 278 468 1,774
63 63 62 66 69 73 74 77 77 81 84 81 82 82 85 89 89 98 101 100 101 106 106 107 108 116 107 112 111 109 116 117 125 135 140 143 142 145 147 146 580
16 17 17 20 17 25 19 15 19 8.0 17 15 12 12 14 17 32 34 18 21 21 19 18 19 18 22 24 16 18 19 22 20 19 27 22 21 20 25 20 23 88
90 110 113 160 107 17 45 46 23 38 6.0 11 7.0 -51 26 31 -42 108 -1.0 -343 -3.0 67 -21 88 107 10 23 2.0 19 – – – – – – – – – – – –
-57 -36 -154 -139 11 -34 -128 -33 75 37 9.0 -10 -16 52 23 36 219 -256 139 72 -42 -82 22 -27 31 93 -252 81 -148 174 -186 -6.0 -42 13 -90 55 35 64 -210 81 -30
61 128 42 65 63 82 73 78 81 151 47 85 96 172 83 82 91 162 86 84 89 144 63 76 118 147 127 104 105 72 104 92 106 123 117 108 144 158 114 138 554
-72 -107 -22 -170 -247 -366 -204 -126 -125 -346 -110 -92 -109 -100 -206 -205 -193 -168 -93 437 -96 -227 -169 -82 -118 -543 -158 -840 -947 -114 -213 -200 -1,633 -502 -115 -124 -201 -191 -152 -134 -678
57 55 62 62 62 61 61 68 69 68 72 71 72 71 71 75 76 75 75 81 76 77 74 78 78 75 74 80 80 80 79 84 84 84 84 90 89 90 88 96 363
-50 -150 -150 -150 -50 -115 -50 39 -100 -172 -53 -50 -50 -200 -75 37 27 -250 -410 -1,500 -1,802 -289 -373 -200 -374 -461 25 47 60 -275 -23 – -1.0 -151 29 42 -150 -300 – -102 –
-2.0 -2.0 -2.0 -1.0 -2.0 28 103 -136 -2.0 159 337 -301 796 796 -801 549 -1.0 -552 -1.0 -1.0 -1.0 -1.0 -1.0 – -1.0 -1.0 -42 319 -42 – – – 1,845 -1.0 -385 -216 0.0 -1.0 -1.0 -6.0 -8.0
-106 -244 -166 -177 -79 -170 11 -189 -146 -77 164 -420 -29 510 -891 496 -52 -820 -566 -1,567 -38 -369 -471 -242 -474 -545 -76 189 -83 130 -153 -363 1,770 -170 -561 -293 -247 -287 -152 -396 -1,082
123 -47 8.0 -53 36 -213 -13 8.0 131 -128 329 -191 161 758 -850 646 617 -447 72 -670 427 -115 -160 78 -90 -385 -140 -49 17 543 -212 -203 493 -215 -361 131 113 -12 -27 -63 11
240 176 154 229 299 241 107 245 321 144 228 236 203 176 164 273 771 379 645 376 472 337 417 326 384 187 -33 340 102 455 50 268 250 341 197 436 419 307 164 330 1,220

LTM = last twelve months (sum of the four most recent quarters).

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?